Diabetes Technology

Feature Archive

The 'Artificial Pancreas' Has Arrived

The 'Artificial Pancreas' Has Arrived

FDA approval of the first closed-loop insulin delivery system is exciting for both physicians and patients. What does this mean for the future?

Latest

NIH Announces Major Artificial Pancreas Clinical Trials

NIH Announces Major Artificial Pancreas Clinical Trials

The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.

Continuous Glucose Monitoring Improves HbA1c in T1D

Continuous Glucose Monitoring Improves HbA1c in T1D

Patients with type 1 diabetes who used multiple insulin injections daily experienced reductions in HbA1c with continuous glucose monitoring.

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

The FDA's expanded indication for the Dexcom G5 Continuous Glucose Monitoring System allows for replacement of fingerstick glucose testing.

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients with Diabetes

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients with Diabetes

The system allows patients and their caregivers to access glucose measurements through their pump or through a mobile app.

Contour Next One Glucose Monitoring System Approved by FDA

Contour Next One Glucose Monitoring System Approved by FDA

The Contour®Next One Blood Glucose Management System will be available in early 2017.

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

An implantable continuous glucose monitor appears to be a safe and effective alternative to a transcutaneous monitor in diabetes.

The 'Artificial Pancreas' Has Arrived

The 'Artificial Pancreas' Has Arrived

FDA approval of the first closed-loop insulin delivery system is exciting for both physicians and patients. What does this mean for the future?

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

Approval was based on a clinical trial that included 123 people with type 1 diabetes who used the MiniMed 670G hybrid closed-loop system for 3 months, after a 2-week period of no use.

Artificial Pancreas Moving Steadily Toward Commercial Approval

Artificial Pancreas Moving Steadily Toward Commercial Approval

The FDA is coordinating with investigators, manufacturers, clinicians, and others to bring automated insulin delivery devices to market.

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

The system was feasible, safe, and effective for managing hyperglycemia in this patient population.

Sign Up for Free e-Newsletters